All Vaccinology articles – Page 23
-
NewsFrom ‘hit to vial’: Discovery and optimization of a promising vaccine adjuvant
Scientists identified a new and promising adjuvant, dubbed PVP-037 - in principle, this compound can be added to any vaccine to enhance its action.
-
NewsMobile phone data helps track pathogen spread and evolution of superbugs
Combining genomic data and human travel patterns over a 14-year period in South Africa reveals key insights into the spread, evolution and resistance patterns of a major bacterium behind pneumonia and meningitis globally.
-
NewsRegular vaccine boosts may help people who are immunocompromised fight Covid-19
New research finds booster doses of bivalent vaccines given every three to six months helps maintain a person’s ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5.
-
NewsSRI is developing a new malaria treatment that aims to protect from the disease
The injectable formulation is affordable, easily administered, and could potentially provide months of protection from the potentially fatal disease.
-
NewsA new viral target could help combat the global measles resurgence
A multinational research team has identified a novel way to attack measles, paving the way for new vaccines and antiviral drugs that could help combat the virus’s global resurgence.
-
FeaturesInfection, immunity and the One Health response in Indonesia
Infectious diseases (IDs) are a major health issue in Indonesia, as in many tropical low- and middle-income countries (LMICs), placing a significant economic burden on limited resources. Vaccination may have a critical role to play in the prevention of zoonotic infectious diseases.
-
NewsImaging measles fusion process reveals pathway to powerful weapon
Scientists have harnessed an imaging technique called cryo-electron microscopy to show—in unprecedented detail—how a powerful antibody can neutralize the measles virus before it completes the process of fusing into the host cell membrane.
-
NewsEdited BCG offers potential vaccine to prevent tuberculosis in people of all ages
TB remains the leading cause of death by infectious disease globally, with South Africa having one of the highest incidence rates in the world. Source: Y tambe Apparatus for BCG vaccination - Kuchiki’s needle While the BCG vaccine used to prevent TB is widely available for infants, ...
-
NewsSocial media use is associated with more frequent vaccination
Researchers have found that more social media use correlates with more vaccination – though the reason for this relationship is different for Democrats and Republicans.
-
NewsResearchers advise strengthening immunity against COVID-19 in people with cancer
Researchers who led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia, have recommended administering additional doses of the vaccine among this risk population.
-
NewsRecombinant protein offers potential as TB booster vaccine
No new vaccine has yet surpassed BCG, which is a highly effective live vaccine and is very effective in preventing tuberculosis in children. Creating a booster vaccine to strengthen immunity in adults is considered a promising and realistic option.
-
NewsScientists uncover risk factors for long Covid
A study has found that people with a milder Covid-19 infection—including those who were vaccinated against SARS-CoV-2 and those who were infected with an Omicron variant—were more likely to recover quickly.
-
NewsMothers have lower risk of caesarean births after COVID vaccination
Pregnant women who have been vaccinated against Covid-19 are less likely to have a caesarean section or experience hypertension, according to a study.
-
NewsIntranasal COVID-19 vaccine headed to clinical trials
CyanVac will sponsor a randomized, double-blind Phase 2b study to compare the efficacy and safety of CVXGA, its intranasal vaccine candidate designed to protect against COVID-19, against an FDA-approved mRNA-based COVID-19 vaccine.
-
NewsFeeling rough after your COVID shot? That means it’s working!
Side effects of the Covid vaccine may include tiredness, muscle and joint pain, chills, headache, fever or nausea, but a new study finds that the symptoms indicate a robust immune response that is likely to lessen the chances of infection.
-
NewsStudy finds no association between COVID-19 vaccines and stillbirths
In a new study funded by the U.S. Centers for Disease Control and Prevention, researchers found “no association between COVID-19 vaccination and stillbirth”.
-
NewsItaly pertussis outbreak hospitalises 108 and claims 3 lives
A significant pertussis outbreak, predominantly affecting neonates and young infants, saw 108 hospitalisations and three deaths. Its resurgence may be attributed to limited maternal immunisation during pregnancy and increased circulation post-COVID-19 pandemic.
-
NewsVaccine approach offers promise to induce longer-lasting protective immunity against COVID-19
A scientific team has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.
-
NewsFalse belief in MMR vaccine-autism link endures as measles threat persists
As measles cases rise across the United States and vaccination rates for the MMR (measles, mumps, rubella) vaccine fall, a new survey finds that a quarter of U.S. adults do not know that claims that the MMR vaccine causes autism are false.
-
News$1.3m funding will help scientists to contribute to the eradication of polio
Scientists have received a $1.3 million grant from the Bill & Melinda Gates Foundation to develop and validate a novel and safe approach for measuring immune responses to polioviruses.